ReviewHuman vaccines & immunotherapeutics2016

Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management.

Paola Savoia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.